These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10563309)

  • 1. Glucosylceramide synthase: assay and properties.
    Shayman JA; Abe A
    Methods Enzymol; 2000; 311():42-9. PubMed ID: 10563309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucosyceramide synthase of mouse kidney: further characterization with an improved assay method.
    Shukla GS; Radin NS
    Arch Biochem Biophys; 1990 Dec; 283(2):372-8. PubMed ID: 2148864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide glucosylation in bean hypocotyl microsomes: evidence that steryl glucoside serves as glucose donor.
    Lynch DV; Criss AK; Lehoczky JL; Bui VT
    Arch Biochem Biophys; 1997 Apr; 340(2):311-6. PubMed ID: 9143336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
    Kartal Yandım M; Apohan E; Baran Y
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid and simple assay method for UDP-glucose:ceramide glucosyltransferase.
    Matsuo N; Nomura T; Imokawa G
    Biochim Biophys Acta; 1992 Apr; 1116(2):97-103. PubMed ID: 1533793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning and characterization of the mouse ceramide glucosyltransferase gene.
    Ichikawa S; Ozawa K; Hirabayashi Y
    Biochem Biophys Res Commun; 1998 Dec; 253(3):707-11. PubMed ID: 9918791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosphingolipids in Plasmodium falciparum. Presence of an active glucosylceramide synthase.
    Couto AS; Caffaro C; Uhrig ML; Kimura E; Peres VJ; Merino EF; Katzin AM; Nishioka M; Nonami H; Erra-Balsells R
    Eur J Biochem; 2004 Jun; 271(11):2204-14. PubMed ID: 15153110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy.
    Fox TE; Han X; Kelly S; Merrill AH; Martin RE; Anderson RE; Gardner TW; Kester M
    Diabetes; 2006 Dec; 55(12):3573-80. PubMed ID: 17130506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose availability and glycolytic metabolism dictate glycosphingolipid levels.
    Stathem M; Marimuthu S; O'Neal J; Rathmell JC; Chesney JA; Beverly LJ; Siskind LJ
    J Cell Biochem; 2015 Jan; 116(1):67-80. PubMed ID: 25145677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of glucosylceramide and glucosylceramide synthase in liver disease: from bench to bedside - Review.
    Gan J; Zheng SJ; Mao XR; Li JF
    Acta Biochim Pol; 2020 Dec; 68(1):33-39. PubMed ID: 33355876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of glucosylceramide synthase.
    Shayman JA; Lee L; Abe A; Shu L
    Methods Enzymol; 2000; 311():373-87. PubMed ID: 10563341
    [No Abstract]   [Full Text] [Related]  

  • 12. WP1066, a small molecule inhibitor of the JAK/STAT3 pathway, inhibits ceramide glucosyltransferase activity.
    Tsurumaki H; Katano H; Sato K; Imai R; Niino S; Hirabayashi Y; Ichikawa S
    Biochem Biophys Res Commun; 2017 Sep; 491(2):265-270. PubMed ID: 28739255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucosylceramide synthase and glycosphingolipid synthesis.
    Ichikawa S; Hirabayashi Y
    Trends Cell Biol; 1998 May; 8(5):198-202. PubMed ID: 9695839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Glucosylceramide Synthesis in the Treatment of Rare and Common Renal Disease.
    Shayman JA
    Semin Nephrol; 2018 Mar; 38(2):183-192. PubMed ID: 29602400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus.
    Zador IZ; Deshmukh GD; Kunkel R; Johnson K; Radin NS; Shayman JA
    J Clin Invest; 1993 Mar; 91(3):797-803. PubMed ID: 8450061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of glycosphingolipid, sulfatide, and ceramide in the polycystic (cpk/cpk) mouse.
    Deshmukh GD; Radin NS; Gattone VH; Shayman JA
    J Lipid Res; 1994 Sep; 35(9):1611-8. PubMed ID: 7806975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical manipulation of sphingolipid biosynthesis using photoswitchable ceramides.
    Kol M; Williams B; Toombs-Ruane H; Franquelim HG; Korneev S; Schroeer C; Schwille P; Trauner D; Holthuis JC; Frank JA
    Elife; 2019 Feb; 8():. PubMed ID: 30720434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Evaluation of Hybrid Structures Composed of Two Glucosylceramide Synthase Inhibitors.
    van den Berg RJ; van Rijssel ER; Ferraz MJ; Houben J; Strijland A; Donker-Koopman WE; Wennekes T; Bonger KM; Ghisaidoobe AB; Hoogendoorn S; van der Marel GA; Codée JD; Overkleeft HS; Aerts JM
    ChemMedChem; 2015 Dec; 10(12):2042-62. PubMed ID: 26492941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compartmentation and topology of glucosylceramide synthesis.
    Cantatore JL; Murphy SM; Lynch DV
    Biochem Soc Trans; 2000 Dec; 28(6):748-50. PubMed ID: 11171193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of glucosylceramide and sterol glucoside by a UDP-glucose-dependent glucosylceramide synthase from cotton expressed in Pichia pastoris.
    Hillig I; Leipelt M; Ott C; Zähringer U; Warnecke D; Heinz E
    FEBS Lett; 2003 Oct; 553(3):365-9. PubMed ID: 14572652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.